The estimated Net Worth of Mark G. Eller is at least 436 千$ dollars as of 13 August 2011. Mark Eller owns over 690 units of Jazz Pharmaceuticals plc stock worth over 436,395$ and over the last 14 years Mark sold JAZZ stock worth over 0$.
Mark has made over 1 trades of the Jazz Pharmaceuticals plc stock since 2011, according to the Form 4 filled with the SEC. Most recently Mark exercised 690 units of JAZZ stock worth 72,540$ on 13 August 2011.
The largest trade Mark's ever made was exercising 690 units of Jazz Pharmaceuticals plc stock on 13 August 2011 worth over 72,540$. On average, Mark trades about 230 units every 0 days since 2011. As of 13 August 2011 Mark still owns at least 4,151 units of Jazz Pharmaceuticals plc stock.
You can see the complete history of Mark Eller stock trades at the bottom of the page.
Mark's mailing address filed with the SEC is C/O JAZZ PHARMACEUTICALS, INC., 3180 PORTER DRIVE, PALO ALTO, CA, 94304.
Over the last 17 years, insiders at Jazz Pharmaceuticals plc have traded over 1,513,676,247$ worth of Jazz Pharmaceuticals plc stock and bought 1,319,315 units worth 25,188,964$ . The most active insiders traders include Michael W Michelson、Patrick G Enright、Jp Iii Llckkr Partners Iii,.... On average, Jazz Pharmaceuticals plc executives and independent directors trade stock every 11 days with the average trade being worth of 5,162,934$. The most recent stock trade was executed by Mary Elizabeth Henderson on 6 September 2024, trading 1,410 units of JAZZ stock currently worth 152,703$.
jazz pharmaceuticals plc (nasdaq: jazz) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. we are a diverse company of over 875 employees focused on portfolio of products and/or product candidates in the areas of sleep, hematology/oncology and pain. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has u.s. offices in palo alto, ca and philadelphia, pa, and has offices in various other locations in europe. the company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what is done to accomplish results by operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. we plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our uni
Jazz Pharmaceuticals plc executives and other stock owners filed with the SEC include: